Stocks and InvestingStocks and Investing
Tue, November 30, 2021
Mon, November 29, 2021
Fri, November 26, 2021
Wed, November 24, 2021
Tue, November 23, 2021

Justin Smith Upgraded (ABBV) to Strong Buy and Held Target at $172 on, Nov 23rd, 2021


Published on 2024-10-27 18:45:30 - WOPRAI, Justin Smith
  Print publication without navigation


Justin Smith of Societe Generale, Upgraded "AbbVie Inc." (ABBV) to Strong Buy and Held Target at $172 on, Nov 23rd, 2021.

Justin has made no other calls on ABBV in the last 4 months.



There are 8 other peers that have a rating on ABBV. Out of the 8 peers that are also analyzing ABBV, 2 agree with Justin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Carter Gould of "Barclays" Maintained at Hold with Increased Target to $118 on, Monday, November 1st, 2021
  • Geoff Meacham of "B of A Securities" Maintained at Hold with Increased Target to $119 on, Monday, August 2nd, 2021


These are the ratings of the 6 analyists that currently disagree with Justin


  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $129 on, Monday, November 1st, 2021
  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Decreased Target to $135 on, Monday, November 1st, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $124 on, Monday, November 1st, 2021
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $132 on, Monday, November 1st, 2021
  • Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $130 on, Monday, August 23rd, 2021
  • Robyn Karnauskas of "Truist Securities" Initiated at Strong Buy and Held Target at $118 on, Monday, July 26th, 2021